CardioBrief: Novel HDL Drug Flop Ends Its Development

(MedPage Today) -- With efficacy fizzle in pilot trial, ApoA-1 Milano appears to be dead
via CardioBrief: Novel HDL Drug Flop Ends Its Development
by